The stock has a 36-month beta value of 0.89. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for EKSO is 2.11M, and at present, short sellers hold a 3.64% of that float. On June 18, 2025, the average trading volume of EKSO was 147.05K shares.
EKSO) stock’s latest price update
Ekso Bionics Holdings Inc (NASDAQ: EKSO)’s stock price has plunge by -3.08relation to previous closing price of 3.90. Nevertheless, the company has seen a -10.64% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-18 that AI voice agent for user interface being designed to support exoskeleton device operation, motivation, training, and safety First proof-of-concept demonstration comes just over a month after Company announced its acceptance into the NVIDIA Connect Program SAN RAFAEL, Calif., June 18, 2025 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has successfully demonstrated initial proof-of-concept in integrating artificial intelligence (“AI”)-enabled capabilities across its portfolio of Enterprise Health and Personal Health exoskeleton devices.
EKSO’s Market Performance
Ekso Bionics Holdings Inc (EKSO) has seen a -10.64% fall in stock performance for the week, with a -23.87% decline in the past month and a -43.88% plunge in the past quarter. The volatility ratio for the week is 4.71%, and the volatility levels for the past 30 days are at 5.68% for EKSO. The simple moving average for the past 20 days is -10.15% for EKSO’s stock, with a -61.43% simple moving average for the past 200 days.
EKSO Trading at -30.65% from the 50-Day Moving Average
After a stumble in the market that brought EKSO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.53% of loss for the given period.
Stock Fundamentals for EKSO
Current profitability levels for the company are sitting at:
- -0.61 for the present operating margin
- 0.53 for the gross margin
The net margin for Ekso Bionics Holdings Inc stands at -0.62. The total capital return value is set at -0.57. Equity return is now at value -80.71, with -38.36 for asset returns.
Based on Ekso Bionics Holdings Inc (EKSO), the company’s capital structure generated 0.31 points at debt to capital in total, while cash flow to debt ratio is standing at -1.49. The debt to equity ratio resting at 0.44. The interest coverage ratio of the stock is -76.03.
Currently, EBITDA for the company is -9.45 million with net debt to EBITDA at -0.57. When we switch over and look at the enterprise to sales, we see a ratio of 0.83. The receivables turnover for the company is 2.72for trailing twelve months and the total asset turnover is 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.35.
Conclusion
To sum up, Ekso Bionics Holdings Inc (EKSO) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
